Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer
Eligible for screening study DCP 001
For CCTG MA.39, please credit NRG all accruals.
CCTG MA.39 is closed to accrual, effective June 30, 2026.
CCTG MA.39-Optional Questionnaire Component is closed to accrual effective August 2, 2022
